Rojas-Velázquez JM, Machín-Legón M, Giralt-Herrera A

Language: Spanish
References: 8
Page: 1-3
PDF size: 206.47 Kb.

Text Extraction

No abstract.

REFERENCES

1. Whelton PK, Carey RM, Aronow WS, CaseyJr DE, Collins KJ, DennisonHimmelfarb C, et al. 2017 ACC/ AHA/ AAPA/ ABC/ ACPM AGS/APhA/ ASH/ ASPC/ NMA/ PCNA. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am CollCardiol. 2018:71(6):1269-324.

2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality:A meta-analysis of individual data for one million adults in 61prospective studies. Lancet. 2002;360:1903-13.

3. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, BöhmM, et al. Guía de práctica clínica de la ESH/ESC 2013 para el manejo de la hipertensión arterial. Rev EspCardiol. 2013;66(10):880.e1-880.e64.

4. James PA, Oparil S, Carter BL, Cushman WC, Dennison Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20.

5. Comisión Nacional Técnica Asesora del Programa de Hipertensión Arterial. Guía Cubana de Diagnóstico, Evaluación y Tratamiento de la Hipertensión Arterial. Cuba: MINSAP; 2017.

6. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-16.

7. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al. Effects of intensive blood-pressure control intype 2 diabetes mellitus. N Engl J Med. 2010;362:1575-85.

8. Xie X, Atkins E, Lu J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387:435-43.